Pacemaker, Perm. & Temp., Electrode
by Daig Corp. 510(k)
Active
510(k) K772197
Overview
This device is a Permanent Pacemaker Electrode, classified under product code DTB, designed for both permanent and temporary cardiac pacing applications. It delivers electrical impulses to regulate heart rhythm in patients with bradycardia or conduction system disorders, ensuring proper cardiac function through direct myocardial stimulation.
The device is supplied as a reusable medical component, intended for use in clinical settings such as cardiac catheterization labs or operating rooms. It requires sterile handling and is regulated under FDA 510(k) clearance (K772197), with a decision date of January 30, 1978, under the traditional review pathway. Compliance with 870.3680 regulatory standards ensures its safety and performance for cardiovascular applications.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK772197 | Date30 Jan 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Other devices from Daig Corp.
Questions
Is this pacemaker electrode designed for single-use or can it be reused in multiple patients?
This pacemaker electrode is intended for reusable use in clinical settings like cardiac catheterization labs or operating rooms. It is classified as a reusable medical component, meaning it is meant to be sterilized and reused after proper cleaning and processing between patients, rather than being discarded after a single use.
What types of heart conditions is this electrode intended to address, and how does it work?
This electrode is designed for both permanent and temporary cardiac pacing to address bradycardia (slow heart rate) or conduction system disorders, where the heart’s natural electrical signals are impaired. It delivers controlled electrical impulses directly to the heart muscle (myocardium) to regulate rhythm and ensure proper cardiac function.
How should this electrode be handled during use, and what sterility precautions are required?
Since this electrode is reusable, it must be handled under sterile conditions during each use. While it is not a single-use device, it requires proper sterilization between procedures to prevent infection. Clinicians should follow established protocols for cleaning, disinfection, and sterilization to maintain safety and compliance with medical device regulations.
What regulatory pathway was followed for FDA clearance, and what does that mean for its safety?
This device received FDA 510(k) clearance (K772197) under the traditional review pathway, with a decision date of January 30, 1978. The clearance was based on a determination of substantial equivalence to a predicate device, meaning it was found to have the same intended use and technological characteristics as a previously approved device. Compliance with FDA regulation 870.3680 further ensures its safety and performance for cardiovascular applications.
Are there multiple sizes or models available for this electrode, and how would a clinician determine the correct fit?
While the provided data does not specify exact sizes or model variations, the device is listed under OpenFDA registration numbers (e.g., 3002618605, 1028232) which may correspond to different electrode configurations or lead types. Clinicians should consult manufacturer documentation or product catalogs to select the appropriate size, length, or fixation mechanism based on patient anatomy, pacing requirements, and procedural needs (e.g., temporary vs. permanent implantation).